系统性硬化症原发性心肌病:文献综述为英国心脏工作组提供依据
该综述旨在为英国系统性硬化症研究组心脏工作组制定最佳实践路径提供信息,描述了SSc-心肌病的患病率、相关死亡率增加及多种表现(如心力衰竭、心律失常和舒张功能障碍),并指出有限证据提示其与弥漫性皮肤病变、SSc特异性抗体阳性等不良预后指标相关。
要点
- SSc-心肌病患病率较高且与死亡率增加相关。
- 鉴别SSc-心肌病与缺血性心脏病需精心设计的研究。
- 有限证据提示弥漫性皮肤病变等为不良预后指标。
核心结论
- SSc-心肌病是SSc中常见且预后不良的疾病,与多种不良预后指标相关,但鉴别诊断仍需进一步研究。
研究设计与样本
- comprehensive literature review performed to inform the UK Systemic Sclerosis Study Group cardiac working group.
主要发现
- SSc-心肌病患病率较高,与死亡率增加相关。
- SSc-心肌病表现包括心力衰竭、心律失常和舒张功能障碍。
- 有限证据提示SSc-心肌病与弥漫性皮肤病变、SSc特异性血清学阳性、黑种人、发病年龄较大、肌腱摩擦音、甲襞毛细血管镜异常和较差的生活质量评分相关。
关键数值与推荐
- SSc-心肌病与弥漫性皮肤病变、SSc特异性血清学阳性、黑种人、发病年龄较大、肌腱摩擦音、甲襞毛细血管镜异常和较差的生活质量评分相关(基于有限证据)。
临床怎么用
- 临床应关注SSc患者的心脏受累,尤其是存在弥漫性皮肤病变、SSc特异性抗体阳性等不良预后指标者。
- 鉴别SSc-心肌病与缺血性心脏病需精心设计的研究。
- 无创检查技术有助于理解SSc-心肌病的病理生理基础。
局限性
- 证据有限,SSc-心肌病的疾病表型及风险因素尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac disease is prevalent in SSc and associated with a poor prognosis. Differentiating primary myocardial disease (SSc-cardiomyopathy) from ischaemic heart disease is difficult and the disease phenotype most at risk is unclear. A comprehensive literature review was performed to inform the UK Systemic Sclerosis Study Group for cardiac disease tasked with producing a best practice pathway for the management of cardiac disease in SSc. This review describes the prevalence of SSc-cardiomyopathy, its associated greater mortality and various manifestations (e.g. heart failure, arrhythmias and diastolic dysfunction). The limited evidence suggests SSc-cardiomyopathy is associated with other poor prognostic indicators, including diffuse cutaneous disease, positive SSc-specific serology, black ethnicity, older age at disease onset, tendon friction rubs, abnormal nail-fold capillaroscopy and worse quality-of-life scores. Differentiating SSc-cardiomyopathy from ischaemic heart disease requires well-planned studies. Non-invasive investigative techniques are improving the understanding of its pathophysiological basis.
引用
- Bissell LA, Md Yusof MY, Buch MH, et al. Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group. Rheumatology (Oxford). 2017. PMID: 27940590. doi:10.1093/rheumatology/kew364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。